Big Pharma Looking For Generic Connections

President Obama has recently indicated he will be turning some of his attention to the health care system and early articles and news releases seem to indicate that at least a portion of his plan will fit right with the theme of 2oversold.com and what we look for in companies.

Most of our selections over the past year has been more directed towards the “2oversold” side of the equation but readers of our blog know that is only one of the criteria we look for: the other is “value”.

Generic Drug related companies will fit the value side of our equation perfectly. This is an area that should garner much attention as the economy continues to falter and during inflationary times.

Over the coming weeks we will be blogging about some pharma/bio-tech companies that we think are worth a look. This will be based on either price or the value they provide the consumer and that they may also be candidates for possible merger or buyout by big pharma.

For those who have not considered this area of the market perhaps now is a good time to start focusing on a few quality companies that may warrant your attention.

2oversold.com is a blog for the individual consumer and private investor. We are not experts in the markets nor do we make any recommendations of any company. The companies we blog about are discussed for the purposes of this blog only and this should not be considered as investment advice.